![Margaret Pax](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 410 821 $ in data 30/06/2026
Ms. Margaret A. Pax is an Independent Director at Repligen Corp.
and an Independent Director at Jellagen Pty Ltd. She is on the Board of Directors at Repligen Corp., BioPorto, Inc., Harvard Business School Health Industry Alumni Association and Jellagen Pty Ltd. Ms. Pax was previously employed as an Independent Director by Alimera Sciences, Inc., a Vice President-Business Development by Microchips Biotech, Inc., and a Vice President-Marketing by OmniSonics Medical Technologies, Inc. She also served on the board at Bioporto A/S.
She received her undergraduate degree from the College of the Holy Cross (Massachusetts) and an MBA from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
REPLIGEN CORPORATION 0,01% | 14/05/2026 | 3.011 ( 0,01% ) | 410 821 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| REPLIGEN CORPORATION | Direttore/Membro del Consiglio | 18/03/2024 |
Bioporto, Inc. | Direttore/Membro del Consiglio | - |
Jellagen Pty Ltd.
 Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Produces research grade functional non-mammalian collagen products | Direttore/Membro del Consiglio | - |
Harvard Business School Health Industry Alumni Association | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ALIMERA SCIENCES, INC. | Direttore/Membro del Consiglio | 16/09/2024 |
| BIOPORTO A/S | Direttore/Membro del Consiglio | - |
OmniSonics Medical Technologies, Inc.
 OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Vendite & Marketing | - |
Microchips Biotech, Inc.
 Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Bioporto A/S
 Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Health Technology |
Harvard Business School Health Industry Alumni Association | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Produces research grade functional non-mammalian collagen products | Consumer Non-Durables |
Bioporto, Inc. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
